Top Markets
#1 DogBull DogBull +105.13%
#2 Siacoin Siacoin +54.09%
#3 ADO Protocol ADO Protocol +46.53%
#4 MarsCoin MarsCoin +44.60%
#5 UnifAI Network UnifAI Network +44.55%
#6 Useless Coin Useless Coin +23.36%
#7 Magma Finance Magma Finance +22.74%
#8 Ontology Gas Ontology Gas +22.45%
#9 Apertum Apertum +14.61%
#10 Filecoin Filecoin +13.89%
Coin of the day
DogBull DogBull
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Opus Genetics, Inc. Opus Genetics, Inc.

Opus Genetics, Inc.

IRD
Kedudukan dalam Saham #16217
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Harga Saham
$3.70
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$305.87M
Perubahan (1 hari)
-3.53%
Perubahan (1 tahun)
203.66%
Negara
US
Perdagangan Opus Genetics, Inc. (IRD)

Kategori

Healthcare
Sejarah hasil dividen untuk Opus Genetics, Inc. (IRD)
Hasil dividen (TTM) bagi Opus Genetics, Inc. (simbol saham: IRD) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Opus Genetics, Inc. (IRD) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.48%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH